Clover Health Investments, Corp. (CLOV) — Analyst outlook / Analyst consensus target is. Based on 9 analyst ratings, the consensus is bearish — 1 Buy, 5 Hold, 3 Sell.
The consensus price target is $3.00, representing an upside of 47.1% from the current price $2.04.
Analysts estimate Earnings Per Share (EPS) of $-0.12 and revenue of $1.38B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.08 vs est $-0.12 (beat +32.5%). 2025: actual $-0.17 vs est $-0.17 (beat +1.7%). Analyst accuracy: 75%.
CLOV Stock — 12-Month Price Forecast
$3.00
▲ +47.06% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for Clover Health Investments, Corp., the price target is $3.00.
The average price target represents a +47.06% change from the last price of $2.04.
CLOV Analyst Ratings
Hold
Based on 9 analysts giving stock ratings to Clover Health Investments, Corp. in the past 3 months
EPS Estimates — CLOV
75%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual –$0.08
vs Est –$0.12
▲ 48.1% off
2025
Actual –$0.17
vs Est –$0.17
▲ 1.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — CLOV
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $1.371B
vs Est $1.382B
▼ 0.8% off
2025
Actual $1.924B
vs Est $1.904B
▲ 1.1% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
